Klaus Christian Mende1, Teresa Kellner1, Stephan Petersenn2, Juergen Honegger3, Rocío Evangelista-Zamora3, Michael Droste4, Guenter Stalla5, Timo Deutschbein6, Yawen Wang7, Dag Moskopp7, Ulrich Knappe8, Katharina Schilbach9, Joerg Flitsch1. 1. Department of Neurosurgery, Hamburg University Medical Center, Hamburg, Germany. 2. ENDOC Praxis für Endokrinologie, Andrologie und medikamentöse Tumortherapie, Hamburg, Germany. 3. Department of Neurosurgery, University of Tuebingen, Tuebingen, Germany. 4. Medicover Oldenburg MVZ, Oldenburg, Germany. 5. Max-Planck-Institut für Psychiatrie, Munich, Germany. 6. Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, Würzburg, Germany. 7. Vivantes Klinikum im Friedrichshain, Berlin, Germany. 8. Department of Neurosurgery, Johannes Wesling Klinikum Minden, Ruhr University Bochum, Minden, Germany. 9. Ludwig-Maximilians-University of Munich, Department of Internal Medicine IV, Munich, Germany.
Authors: Michael S Rutenberg; Adam L Holtzman; Daniel J Indelicato; Soon Huh; Dinesh Rao; Peter J Fiester; Christopher G Morris; Daryoush Tavanaiepour; Robert J Amdur Journal: J Neurooncol Date: 2022-03-12 Impact factor: 4.130